2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow T-VEC: new trials by email Literature Review of T-VEC trials Research Report on T-VEC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma T-VEC - Angiosarcoma of Skin | Phase 2 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 5 | 2019-08-20 | 2022-11-01 |
| Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery Laboratory Biomarker Analysis, Talimogene Laherparepvec - Malignant Chest Wall Neoplasm, Recurrent Breast Carcinoma | Phase 2 | Terminated | M.D. Anderson Cancer Center | 11 | 2016-08-01 | 2023-01-25 |
Breast Neoplasms (1) · Hemangiosarcoma (1) · Inflammatory Breast Neoplasms (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · M.D. Anderson Cancer Center (1)
United States (2)
John Mullinax, MD, (1) · Naoto T Ueno (1)
P30CA016672 (1)